Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,339

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,860

Class I recallsReasonable probability of serious health consequences

24,450

Class II recallsTemporary or medically reversible health consequences

2,901

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,095 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/imperio-distribution-llc-recalls-beef-jerky-products-produced-without-benefitPublished October 24, 2026

Most affected stateHawaii 200 recalls mention this state

State: GU ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 27, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,450
Class I	9,860
Class III	2,901
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,450
Class I	9,860
Class III	2,901
Not Yet Classified	2

FDA Recall TerminatedTerminated: September 29, 2022Historical recordClass II

Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL), 2 mL Single-dose Vial, Each Tray contains 25 Vials, Intravenous or Intramuscular Use, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045, NDC 00409-9094-12 (vial), 00409-9094-22 (tray).

by Pfizer Inc.

Reason: Defective Container: confirmed customer reports for vials with loose metal overseal crimp defects, which may result in lack of assurance of sterility.
Published: February 19, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 26, 2021Historical recordClass II

Ethacrynate Sodium for Injection, USP, 50mg/vial, Single Dose Vial, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-246-01.

by Zydus Pharmaceuticals USA Inc

Reason: cGMP Deviations
Published: February 19, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 23, 2024Historical recordClass I

Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.

by Taro Pharmaceuticals U.S.A., Inc.

Reason: Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Published: February 19, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 16, 2022Historical recordClass III

Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09

by Macleods Pharma Usa Inc

Reason: Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
Published: February 12, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 29, 2022Historical recordClass II

Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11.

by Graviti Pharmaceuticals Private Limited

Reason: Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
Published: February 12, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 10, 2020Historical recordClass II

Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2465-01

by Teva Pharmaceuticals USA

Reason: GMP Deviations: Product bottle may be absent of desiccant.
Published: February 12, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 10, 2020Historical recordClass II

Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01

by Teva Pharmaceuticals USA

Reason: GMP Deviations: Product bottle may be absent of desiccant.
Published: February 12, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: January 8, 2021Historical recordClass III

Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816. NDC 29300-135-01

by UNICHEM PHARMACEUTICALS USA INC

Reason: Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.
Published: February 12, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 29, 2021Historical recordClass II

Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.

by Ascend Laboratories LLC

Reason: cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.
Published: February 12, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass III

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

by Ascend Laboratories LLC

Reason: Failed Dissolution Specifications: low out of specification results for dissolution testing.
Published: February 12, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 3, 2021Historical recordClass II

Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16

by Pharmaceutical Associates Inc

Reason: Subpotent: Out of specification for assay at the 12-month time point.
Published: February 5, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: April 26, 2021Historical recordClass III

Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India NDC 33342-111-10

by Macleods Pharma Usa Inc

Reason: Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product
Published: February 5, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 6, 2020Historical recordClass II

Walgreens Acne Cleansing Bar, Benzoyl Peroxide 10%, NET WT 4 oz (113 g), 1 bar per carton, Distributed By: Walgreen Co., 200 Wilmot Road, Deerfield, IL 60015, NDC: 0363-0137-11

by Shandex Personal Care Manufacturing Inc.

Reason: Presence of Foreign Substance; Metal contaminant visible in product (screen wire from manufacturing).
Published: February 5, 2020
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: January 28, 2020Historical recordClass I

WHOLE FOODS MARKET

Product: 365 Everyday Value Dark Chocolate Caramel Sea Salt Sandwich…
Reason: Potential to contain undeclared milk and coconut.
Published: February 5, 2020
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: January 28, 2020Historical recordClass I

WHOLE FOODS MARKET

Product: 365 Everyday Value Dark Chocolate Peppermint Sandwich Cremes…
Reason: Potential to contain undeclared milk.
Published: February 5, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 8, 2021Historical recordClass III

methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL), SA; Dist by: WEST-WARD, Eatontown, NJ 07724, NDC 0143-9850-01.

by Hikma Pharmaceuticals USA Inc.

Reason: Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.
Published: January 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 12, 2023Historical recordClass II

Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302

by Tuscano and Delucia Group (DBA Entropic Labs)

Reason: Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)
Published: January 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 21, 2023Historical recordClass II

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

by Advanced Accelerator Applications USA, Inc.

Reason: Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Published: January 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 5, 2023Historical recordClass II

Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70934-287-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131

by Denton Pharma, Inc.

Reason: CGMP Deviations: Presence of NDMA impurity detected in product.
Published: January 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 5, 2023Historical recordClass II

Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c). 24-count bottle (NDC 70934-017-24) d). 30-count bottle (NDC 70934-017-30) e). 90-count bottle (NDC 70934-017-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131.

by Denton Pharma, Inc.

Reason: CGMP Deviations: Presence of NDMA impurity detected in product.
Published: January 29, 2020
Distribution: Nationwide

View recall →

Data last updated: October 27, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.